Spinal anesthesia is associated with lower recurrence rates after resection of non-muscle invasive bladder cancer by 沅뚰깭�룞 & �씠湲곗쁺
  Transl Androl Urol 2018;7(2):283-286tau.amegroups.com© Translational Andrology and Urology. All rights reserved.
Heterogeneity of non-muscle invasive bladder 
cancer (NMIBC)
Bladder cancer is a common malignancy involving the 
urinary system, which can be categorized as non-muscle 
invasive and muscle invasive bladder cancer. NMIBC 
comprises of a heterogeneous population of tumor 
and includes pathological stage Ta (confinement to the 
epithelium or mucosa), T1 (invasion into the lamina propria 
without invasion into the muscularis propria) and CIS (Tis: 
flat, high-grade, non-papillary carcinomas confined to the 
urothelium). About 50–70% of all newly diagnosed bladder 
cancers are NMIBC and one third of the remaining cases 
show invasion into deeper layers but are still confined to the 
bladder (1). Of all newly diagnosed NMIBC, 70% present 
as stage Ta, 20% as T1 and 10% as CIS. Approximately 
30–50% of low grade Ta tumor will recur and roughly 
10–20% will progress to muscle invasive disease (2,3). 
In comparison with low-grade stage Ta tumor, T1 high-
grade tumor has a higher recurrence rate around 69–80% 
and a 33% to 48% chance of progression to muscle-
invasive disease. Thereby, T1 high-grade tumors should 
be considered as aggressive and potentially lethal diseases. 
In addition, re-resection (restaging) is required to identify 
whether unrecognized muscle-invasive disease remains 
after surgery (4). T1 tumors are often understaged by 
initial resection. Among T1 tumors, 4–25% shows muscle-
invasiveness in second staging.
Koumpan et al. (5) demonstrated that spinal block 
attenuated tumor recurrence significantly in the high-risk 
patients group but not in the low-risk group, which shows 
the heterogenetic characteristics of the bladder cancer. This 
result also suggests that analysis on specific risk category 
is required because the effects of spinal anesthesia may 
be different depending on tumor categorization within 
NMIBC.
Bladder tumor recurrence and anesthetic 
technique
An incomplete resection, tumor cell implantation, growth 
of microscopic tumors present at the time of the previous 
resection, and new tumor formation are four mechanisms 
underlying bladder cancer recurrence (6). A recurrence in 
the same location as the initial urothelial cancer most likely 
results from residual disease (via incomplete resection and 
tumor cell implantation). A distant recurrence most likely 
results from the growth of microscopic tumors present 
at the time of the previous resection and/or genuine new 
tumor formation. A high proportion of early urothelial 
cancer recurs at the site of the original resection, indicating 
possibility of incomplete resection or tumor cell re-
implantation (7).
In literature, two retrospective studies reported that 
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compared to general anesthesia, spinal anesthesia decreased 
the risk of bladder cancer recurrence after surgery (5,8). 
Possible mechanisms were discussed as following. First, 
surgery under inhalational anesthetic agents impairs cell-
mediated immune activity, especially that of natural killer 
(NK) cells, which controls cancer cell survival and tumor 
spread via chemokine receptor 2 signaling (9). Woods 
et al. (10) demonstrated that inhalational agents such 
as enflurane and halothane produced dose-dependent 
reduction in cytotoxicity of NK cells, which returned to 
normal within 1 hour of discontinuation of the anesthetics. 
On the other hand, Tai et al. (11) reported that surgery 
itself markedly reduced the number of NK cells in the 
spleen and tumor cell killing by NK cells were significantly 
reduced in surgically stressed mice. In the same study, 
human data confirmed that NK cell activity was indeed 
suppressed following the surgery and returns to baseline 
at postoperative day (POD) 28. Another study found that 
major surgery suppressed dopachrome tautomerase (DCT)-
specific CD8+ T cell immunity beginning 24 hours after 
surgery and the suppression lasted for 7–10 days (12). 
Furthermore, in a study NK cell activity after hysterectomy, 
NK cell activity was maintained in patients who received 
extradural anesthesia, which suggests the effectiveness of 
neuraxial anesthesia in reducing surgical stress (13). In 
summary, inhalational anesthetic agents suppress NK cell 
activity but the effect does not last after the surgery. The 
suppression of NK cell activity after the surgery is likely 
due to the surgical stress, which may be blocked via spinal 
anesthesia. Thereby, regional anesthesia compared to 
general anesthesia may result in lower tumor recurrence 
due to mechanisms related to NK cell activity.
Second, local anesthetics may block the voltage-gated 
sodium channels (VGSC) that mediate cancer progression. 
Sodium channel-blocking anti-epileptic drugs such as 
carbamazepine, lamotrigine and topiramate are inversely 
associated with the risks of bladder cancer (14). Wang 
et al. (15) demonstrated that intraoperative lidocaine 
infusion was associated with the preservation of lymphocyte 
proliferation, attenuation of apoptosis, maintenance of the 
balance of Th1/Th2 cells and the decreased production 
of cytokines in patients undergoing radical hysterectomy. 
Obturator nerve block in transurethral bladder resection 
is usually performed with spinal anesthesia to prevent 
obturator reflex and avoid complications such as bleeding, 
bladder perforation, or incomplete tumor resection. Patients 
receive 10 mL 2% preservative free lidocaine along with 
5 mL 0.5% bupivacaine during the procedure. Thereby, 
the additional local anesthetics may contribute to reducing 
recurrence to some degree. Third, volatile anesthetics 
have been shown to upregulate hypoxia inducible factors 
(HIF)-1α and HIF-2α activation, which is a transcriptional 
regulator of vascular endothelial growth factor (VEGF) 
expression mediating proliferation and angiogenesis. 
Overexpression of HIF-1α is associated with enhancement 
of cell proliferation and cell migration (16,17). 
When reviewing journals on the protective mechanisms 
of spinal anesthesia on tumor recurrence, confounding 
factors should be addressed and eliminated to validate 
the results of multivariate regression analysis. For 
example, the multiplicity of tumors can be a confounding 
factor because when bilateral bladder tumor resection is 
planned, general anesthesia may be preferred to regional 
anesthesia which requires spinal block with both obturator 
nerve blocks. Another possible scenario is that bilateral 
bladder tumor might have more lesion sites, which can 
accompany CIS or stage T1 more frequently compared to 
unilateral bladder tumor. These higher multiplicities can 
increase the possibility of incomplete resection and tumor 
reimplantation or unfounded microscopic focus, all which 
are sources of recurrence. Therefore, an association analysis 
between lesion numbers of bladder tumor and choice of 
regional anesthesia should be done to verify whether the 
association is significant.
Koumpan et al. (5) reported interesting findings on 
tumor recurrence. Seventy-two percent of patients who 
received intravesical bacillus Calmette-Guerin (BCG) 
had recurrence, but those who received postoperative 
chemotherapy showed protective effect on recurrence. 
This data mean that in patients who had general anesthesia, 
intravesical BCG did not show any effect on tumor 
suppression. This hypothesis is driven from following 
scenario. On intravesical application of BCG, live BCG 
attaches to the urothelium and is internalized by bladder 
cancer cells, owing to oncogenic aberrations that activate 
macropinocytosis. Following internalization, bladder cancer 
cells upregulate expression of MHC class II and ICAM-1 
and secret cytokines (18). Finally, NK cells and cytotoxic T 
cells migrate to the bladder cancer cells and eliminate the 
tumor cells. However, when surgical stress and inhalational 
anesthetics suppress the activity of NK cells and cytotoxic 
T cells, the effects of intravesical BCG may be not enough 
to kill the tumor cells. Activated macropinocytosis by 
intravesical BCG might rather aid tumor growth than 
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elimination because macropinocytic uptake of extracellular 
proteins provides the much-needed amino acids that 
fuel cancer cell metabolism and tumor growth (15). In 
this perspective, any steps to maintain the immunity 
after surgery should be taken into account. Recently, 
novel anticancer oncolytic vaccine was tried and showed 
promising result (12).
Conclusions
Recently, there has been surmounting evidence that 
supports anesthesia to have a significant effect on cancer 
progression. Thereby, because the method of anesthesia 
may also have critical effects in NMIBC, further prospective 
research is vital in unlocking the key to prevent bladder 
tumor recurrence.
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